DK0910428T3 - Fotoferesebehandling af kroniske HCV-infektioner - Google Patents

Fotoferesebehandling af kroniske HCV-infektioner

Info

Publication number
DK0910428T3
DK0910428T3 DK97916965T DK97916965T DK0910428T3 DK 0910428 T3 DK0910428 T3 DK 0910428T3 DK 97916965 T DK97916965 T DK 97916965T DK 97916965 T DK97916965 T DK 97916965T DK 0910428 T3 DK0910428 T3 DK 0910428T3
Authority
DK
Denmark
Prior art keywords
chronic hcv
hcv infections
patient
treatment
photopheresis treatment
Prior art date
Application number
DK97916965T
Other languages
English (en)
Inventor
Susan N Mclaughlin
Bruce C Stouch
Christopher B O'brien
Original Assignee
Therakos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therakos Inc filed Critical Therakos Inc
Application granted granted Critical
Publication of DK0910428T3 publication Critical patent/DK0910428T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK97916965T 1996-03-29 1997-03-26 Fotoferesebehandling af kroniske HCV-infektioner DK0910428T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1461296P 1996-03-29 1996-03-29

Publications (1)

Publication Number Publication Date
DK0910428T3 true DK0910428T3 (da) 2006-02-13

Family

ID=21766536

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97916965T DK0910428T3 (da) 1996-03-29 1997-03-26 Fotoferesebehandling af kroniske HCV-infektioner

Country Status (13)

Country Link
US (1) US20040062754A1 (da)
EP (1) EP0910428B1 (da)
JP (1) JP2000510003A (da)
CN (1) CN1214636A (da)
AT (1) ATE307634T1 (da)
AU (1) AU717624B2 (da)
BR (1) BR9708406A (da)
CA (1) CA2250920A1 (da)
DE (1) DE69734450T2 (da)
DK (1) DK0910428T3 (da)
ES (1) ES2251020T3 (da)
IL (1) IL126365A0 (da)
WO (1) WO1997036634A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2250919C (en) * 1996-03-29 2008-05-13 Therakos, Inc. Photopheresis treatment of leukocytes
US7049110B2 (en) 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US7498156B2 (en) 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US6219584B1 (en) * 1999-07-09 2001-04-17 Therakos, Inc. Method and system for determining an effective amount of light energy to delivery to fluids having targets for the light energy
US7094378B1 (en) 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US6495366B1 (en) 1999-09-03 2002-12-17 Therakos, Inc. Uninterrupted flow pump apparatus and method
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
AU2002351177A1 (en) 2001-11-29 2003-06-10 Therakos, Inc. Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells
US7211037B2 (en) 2002-03-04 2007-05-01 Therakos, Inc. Apparatus for the continuous separation of biological fluids into components and method of using same
US20040127840A1 (en) 2002-03-04 2004-07-01 Steve Gara Blood separation apparatus and method of using the same
US7186230B2 (en) 2002-03-04 2007-03-06 Therakos, Inc Method and apparatus for the continuous separation of biological fluids into components
US7479123B2 (en) 2002-03-04 2009-01-20 Therakos, Inc. Method for collecting a desired blood component and performing a photopheresis treatment
DE202004004263U1 (de) 2004-03-18 2004-05-19 Weber, Waldfried Bestrahlungsgerät für Blut
CA2628341A1 (en) 2005-11-02 2007-05-18 Therakos Inc. The use of apoptotic cells ex vivo to generate regulatory t cells
EP2527458A3 (en) 2006-05-02 2012-12-26 Therakos, Inc. Methods and reagents for detecting susceptilbility to graft versus host disease
ITVE20070005A1 (it) * 2007-01-25 2008-07-26 Associazione Veneta Per La Lotta Alla Talassemia Farmaco per la cura della talassemia, dell'anemia falciforme e di tutte le altre forme di anemia trattabili con questo, metodo di attivazione del farmaco, composizione farmaceutica avente come principio attivo il farmaco e metodo fotochemioterapico u
US10596387B2 (en) * 2007-04-08 2020-03-24 Immunolight, Llc. Tumor imaging with X-rays and other high energy sources using as contrast agents photon-emitting phosphors having therapeutic properties
US10441810B2 (en) 2007-04-08 2019-10-15 Immunolight, Llc X-ray psoralen activated cancer therapy (X-PACT)
US9358292B2 (en) * 2007-04-08 2016-06-07 Immunolight, Llc Methods and systems for treating cell proliferation disorders
EP3134122B1 (en) * 2014-04-22 2020-06-17 Immunolight, Llc. Tumor imaging using photon-emitting phosphors having therapeutic properties
EP3365017B1 (en) 2015-10-19 2025-12-24 Immunolight, LLC X-ray psoralen activated cancer therapy (x-pact)
AU2021256402A1 (en) * 2020-04-12 2022-11-17 Aethlon Medical, Inc. Devices and methods for treating a coronavirus infection and symptoms thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321919A (en) * 1979-12-11 1982-03-30 Leukocyte Research, Inc. Method and system for externally treating human blood
US4727027A (en) * 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4878891A (en) * 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
US5288605A (en) * 1992-03-02 1994-02-22 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
US5399719A (en) * 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
AU6267596A (en) * 1995-12-14 1997-07-03 Steritech, Inc. Inactivation of non-enveloped virus
CA2250919C (en) * 1996-03-29 2008-05-13 Therakos, Inc. Photopheresis treatment of leukocytes
AU2453697A (en) * 1996-04-10 1997-10-29 Trustees Of The University Of Pennsylvania, The Use of photopheresis in the treatment of chronic infection by hepatitis c virus

Also Published As

Publication number Publication date
AU2544197A (en) 1997-10-22
CN1214636A (zh) 1999-04-21
WO1997036634A1 (en) 1997-10-09
AU717624B2 (en) 2000-03-30
IL126365A0 (en) 1999-05-09
JP2000510003A (ja) 2000-08-08
ATE307634T1 (de) 2005-11-15
DE69734450T2 (de) 2006-08-10
BR9708406A (pt) 2000-01-04
ES2251020T3 (es) 2006-04-16
US20040062754A1 (en) 2004-04-01
DE69734450D1 (de) 2005-12-01
EP0910428A1 (en) 1999-04-28
EP0910428A4 (en) 2001-03-28
EP0910428B1 (en) 2005-10-26
CA2250920A1 (en) 1997-10-09

Similar Documents

Publication Publication Date Title
DK0910428T3 (da) Fotoferesebehandling af kroniske HCV-infektioner
EP0935462A4 (en) TREATMENT OF LEUKOCYTES BY PHOTOPHERESIS
NZ309217A (en) Ribavirin and interferon alpha for the treatment of hepatitis C
ATE186460T1 (de) Methode zur verhinderung von restenosierung nach rekanalisierung von körpergefässen
DE69834724D1 (de) Behandlung von Darm- oder Blasenentzündungen
GEP20002146B (en) Therapeutic Peptide Derivatives
ATE282425T1 (de) Verfahren zur behandlung von endothelialen verletzungen
DE68911061D1 (de) Mittel zur Kontrolle von Thrombenbildungen.
DK0856312T3 (da) Anvendelse af trospiumchlorid til fremstilling af et lægemiddel til behandling af blæresygdomme
DE69902103D1 (de) Behandlung von hepatitis b mit thymosin alpha 1 und lamivudin
KR950701215A (ko) 편두통 치료방법(Treatment of migraine)
ATE228854T1 (de) Immunoglobuline der g-klasse zur lokalen behandlung von hautentzündungen
DK0535129T3 (da) Et antikoagulerende præparat
DK0859630T3 (da) Kombination af termozolomid og alfa-IFN til behandling af fremskreden cancer
RU98119730A (ru) Лечение с помощью фотофереза хронического гепатита с
DK1150981T3 (da) Terapeutisk necleosidforbindelse
RU92011195A (ru) Способ уменьшения дозы химиопрепаратов, используемых для лечения инфекционных заболеваний при одновременном повышении их терапевтической эффективности
UA28207A (uk) Спосіб лікування черепно-мозкової травми
RU92001489A (ru) Препарат для лечения инфекционного гепатита, способ получения препарата и способ лечения гепатита
MY109685A (en) Method for treating hepatitis b carriers with minimal disease
UA29943A (uk) Спосіб лікування хворих на хронічний гепатит
RU95108457A (ru) Способ лечения тяжелых форм глпс
RU94006959A (ru) Способ лечения мочекислого уролитиаза
RU92016457A (ru) Антикоагулирующий препарат